Daily funding roundup - March 22, 2016
Syntimmune bagged $26M; FineHeart recieved investment from Broadview Ventures; Shiftboard landed $4M
- St. Louis, Missouri-based ClubReady, a software provider for the fitness and wellness industry, closed a Series A investment from Level Equity. Financial terms of the investment were not disclosed. In conjunction with the funding, Ben Levin, founder and partner of Level, will join the company’s board.
- Adaptive Technologies, the Louisville, Kentucky-based provider of MobileFit, a platform for fitness facilities and YMCAs to improve the member lifecycle from acquisition to long term retention, raised funding from Queen City Angels (QCA). The amount of the deal was not disclosed. The company plans to use the capital to increase their sales and marketing efforts to further embed their technology in the 2,700 YMCAs and to all fitness facilities.
- Cambridge-based image fusion firm Spectral Edge closed a £1.5 million ($2.14 million) seed funding round. The round was led by IQ Capital and Parkwalk Advisors and also drew support from various other firms including Cambridge Angels, Wren Capital and Cambridge Capital Group. A statement said the new funding would be used to grow Spectral Edge’s team, increase investment in sales and marketing and to continue developing its product portfolio.
- Permission Click Inc., a Winnipeg, Canada-based provider of a platform for schools to create registration forms and permission slips for events and activities, closed a $1.75 million seed funding round. Backers included Friesens Corp. and Real Ventures, among others. The company intends to use the funds to expand operations and school adoption across Canada.
- Medical Departures raised a series A funding round worth $2.5 million. The round was led by Singapore-based venture capital firm Digital Media Partners (DMP), and was joined by VC CyberAgent Ventures, European media firm Hubert Burda Media, and OPT SEA, the Southeast Asia arm of Japanese digital advertising agency OPT Group.
- Shiftboard raised cash to help accelerate sales of its workforce management software platform. The Seattle company landed a $4 million round led by Voyager Capital, with participation from Arnold Venture Group. The company previously raised just $2 million in the past 14 years, so this round is a substantial step.
- FineHeart, a Bordeaux, France-based medical device company focused on innovative technologies in the cardiovascular space, raised €6.41 million (approximately $7.19 million) in Series A financing. The round was led by Broadview Ventures, with participation from M Capital Partners, Sofimac, Galia Gestion, IRDInov, and Aqui invest. The company intends to use the funds to finance the development of its first product.
- Syntimmune, Inc., a development-stage company advancing novel treatments for IgG-mediated autoimmune diseases, made important progress by achieving preclinical proof of concept. It completed preclinical safety testing, triggering a second, $10 million tranche of the Company’s committed $26 million Series A financing. The Series A financing is co-led by Apple Tree Partners and Baxalta Ventures, with participation by the Partners Innovation Fund and additional investors.
If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to mitos@vator.tv.
Image source: e27.co
Mitos Suson
I produce Vator Events and enjoy the challenge. I am learning and growing a lot, being involved with Vator and loving every moment of it!
All author posts